证券代码：300161 证券简称：华中数控 公告编号：2025-086 武汉华中数控股份有限公司 一、基本情况概述 武汉华中数控股份有限公司（以下简称"公司""华中数控"）于 2025 年 6 月 6 日召开了第十二届董事会第三十八次会议、第十二届监事会第十九次会议审议通 过了《关于出售参股公司股权暨关联交易的议案》。公司将间接所持有的参股公 司常州华数锦明智能装备技术研究院有限公司（以下简称"常州华数锦明"）32% 股权进行转让，具体内容详见公司于 2025 年 6 月 7 日在巨潮资讯网上披露的《关 于出售参股公司股权暨关联交易的公告》（公告编号：2025-055）。 二、本次交易进展情况 根据相关协议内容及履约安排，截至本公告披露日，公司收到受让方支付的 部分股权转让款，常州华数锦明已完成上述股权变更事项的工商变更登记手续。 变更完成后，公司不再持有常州华数锦明股权。公司将持续关注后续的进展情况， 并根据规定及时履行信息披露义务。敬请广大投资者理性投资，注意投资风险。 特此公告。 武汉华中数控股份有限公司董事会 二〇二五年九月三十日 关于出售参股公司股权的进展公告 本公司及董事会全体成员保证信息披露内容 ...

Core Viewpoint - The stock of Huazhong CNC has shown a mixed performance in recent trading sessions, with a year-to-date increase of 10.90% but a slight decline in the last five and twenty trading days [1][2]. Financial Performance - As of June 30, 2025, Huazhong CNC reported a revenue of 554 million yuan, representing a year-on-year decrease of 11.91%. However, the net profit attributable to shareholders was -81.45 million yuan, which is a 23.54% increase compared to the previous year [2]. - Cumulative cash dividends since the company's A-share listing amount to 89.19 million yuan, with 9.93 million yuan distributed over the last three years [3]. Shareholder Structure - The number of shareholders as of June 30, 2025, is 28,600, a decrease of 1.14% from the previous period. The average number of circulating shares per person has increased by 1.15% to 6,826 shares [2]. - Notable institutional holdings include Huaxia CSI Robotics ETF, which is the fourth-largest shareholder with 3.12 million shares, an increase of 554,200 shares from the previous period. Tianhong CSI Robotics ETF is the sixth-largest with 1.26 million shares, up by 233,000 shares [3].

每经头条（nbdtoutiao）——5年增长33倍，这类新险种卖爆了，身边很多人都需要，30多家险企蜂拥而 入⋯⋯ 截至发稿，华中数控市值为57亿元。 每经AI快讯，华中数控（SZ 300161，收盘价：28.54元）9月26日晚间发布公告称，截至本公告日，卓 尔智造集团有限公司累计质押股数约为2524万股，占其所持股份比例为45.65%。阎志累计质押股数为 420万股，占其所持股份比例为48.62%。 2024年1至12月份，华中数控的营业收入构成为：制造业占比100.0%。 （记者 曾健辉） ...

证券代码：300161 证券简称：华中数控 公告编号：2025-085 武汉华中数控股份有限公司 关于控股股东部分股份质押及解除质押的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 武汉华中数控股份有限公司（以下简称"公司"）于近日接到控股股东卓尔智 造集团有限公司（以下简称"卓尔智造"）通知，卓尔智造将其所持有的公司部分 股份办理了质押及解押手续，具体事项如下： 本次质押股份不存在被用作重大资产重组业绩补偿等事项的担保或其他保 障用途等情况。 | 二、本次股份解除质押的基本情况 | | --- | | 股东名称 | 是否为控股 股东或第一 | 本次解除质押 | 占其所持股 | 占公司总 | | 起始日 | | 解除日期 | | 质权人 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 大股东及其 | 股份数量（股） | 份比例 | 股本比例 | | | | | | | | | 一致行动人 | | | | | | | | | | | 卓尔智造集 | 是 | ...

Group 1 - The core viewpoint of the article highlights the growth in China's metal cutting machine tool production, with a projected output of 67,000 units in May 2025, representing a year-on-year increase of 6.3% [1] - Cumulative production from January to May 2025 is reported at 332,000 units, showing a cumulative growth of 13.3% [1] - The article references a market research report by Zhiyan Consulting, which provides insights into the machine tool equipment industry in China from 2025 to 2031 [1] Group 2 - Listed companies in the machine tool sector include Chuangjishi (300083), Shenyang Machine Tool (000410), and others, indicating a diverse market landscape [1] - Zhiyan Consulting is recognized as a leading industry consulting firm in China, specializing in in-depth industry research and providing comprehensive consulting services [1]

Group 1 - Albania has appointed an AI robot named "Diela" as the Minister of Public Procurement, making it the first country to do so [1][3] - "Diela" is known to Albanian citizens and operates as a virtual assistant on a digital platform that provides access to government services [3] - The AI is responsible for assisting citizens and businesses in obtaining government documents and providing help through voice commands [3] Group 2 - Huazhong CNC, the first listed company in the domestic CNC system industry, reported a revenue of 554 million yuan, a decrease of 11.91% year-on-year [4][5] - The net loss attributable to shareholders narrowed to 81.45 million yuan, showing a 23.54% improvement compared to the previous year [5] - The CNC system and machine tool sector remains the main revenue driver, generating 363 million yuan with a high gross margin of 41.55%, while the industrial robot segment saw a revenue decline of 23.31% [5] Group 3 - Shanghai Roushen Robot Technology Co., Ltd. completed a multi-million yuan angel round financing to advance smart elderly care robots [6][8] - The company aims to develop robots that can assist elderly individuals in their homes, focusing on real care challenges [8] Group 4 - Mendaera announced the global first clinical application of its handheld surgical robot system, Focalist, for kidney stone removal at the Mayo Clinic [10] - The system integrates handheld robotics with real-time ultrasound imaging to assist surgeons in precise procedures [10] Group 5 - The Zhejiang Province Humanoid Robot Industry Technology Alliance was established to focus on technology development, standard setting, and talent cultivation [11][13] - The alliance includes nearly 40 enterprises, universities, and research institutions, aiming to promote deep integration of industry, academia, and research [13]

Group 1 - The core viewpoint of the article is that the establishment of the "Maturity Evaluation Standard for CNC System Manufacturing" marks a significant step in the standardization of CNC system manufacturing in China, which will provide important technical support for the high-quality development of the machine tool equipment industry [1] Group 2 - The seminar was successfully held on September 11, organized by Wuhan Huazhong Numerical Control Co., Ltd., with participation from over twenty organizations including Huazhong Numerical Control, Chengfei, Hongfeng, and others [1] - The standard discussed is the first item in a series of industrial mother machine standards led by Huazhong Numerical Control, indicating a proactive approach in setting industry benchmarks [1] - The establishment of this standard is expected to promote the high-quality development of the machine tool equipment industry in China [1]

Core Viewpoint - The stock of Huazhong CNC has experienced fluctuations, with a recent decline of 2.06% and a year-to-date increase of 15.61%, indicating volatility in its market performance [1]. Financial Performance - As of June 30, Huazhong CNC reported a revenue of 554 million yuan, a year-on-year decrease of 11.91%, while the net profit attributable to shareholders was -81.45 million yuan, reflecting a growth of 23.54% compared to the previous period [2]. - Cumulative cash dividends since the A-share listing amount to 89.19 million yuan, with 9.93 million yuan distributed over the last three years [3]. Shareholder Information - The number of shareholders decreased by 1.14% to 28,600, while the average circulating shares per person increased by 1.15% to 6,826 shares [2]. - Notable institutional holdings include Huaxia CSI Robotics ETF, which increased its holdings by 554,200 shares, and Tianhong CSI Robotics ETF, which added 233,000 shares [3].

Group 1 - The first national 3D printing drug production license has been issued in Nanjing, marking a significant step in the development and industrialization of 3D printing technology in pharmaceuticals [2] - The licensed entity, Nanjing SanDieJi Pharmaceutical Technology Co., has a production capacity of 300 million 3D printed drug pieces annually, making it the largest commercial production base for 3D printed drugs globally [2] - 3D printing technology offers advantages over traditional pharmaceutical manufacturing, including complex drug structure design, digital drug development, precise drug delivery, and intelligent manufacturing [2] Group 2 - The 3D printing market in China is projected to reach approximately 423 billion yuan in 2024 and is expected to exceed 450 billion yuan by 2025, driven by the increasing application of 3D printing products and the release of pent-up demand for 3D printing equipment [3] - The application fields of 3D printing are expanding, covering industries such as aerospace, automotive, biomedical, construction, and consumer goods, with rapid growth in the consumer electronics sector [3] Group 3 - Seven 3D printing concept stocks have been frequently researched by institutions, with notable companies including Dazong Laser, Aobi Zhongguang-UW, and Yuedan New Materials, among others [5] - The average increase in the stock prices of 3D printing concept stocks this year is 37.05%, with Zhongzhou Special Materials leading with a 192% increase [5][6] - Companies like Aidi Te and Huazhu High-Tech are actively involved in the 3D printing sector, with Aidi Te having launched multiple 3D printers and Huazhu High-Tech developing its own 3D printing equipment and materials [4][5] Group 4 - Xie Chuang Data (300857) has seen its stock price rise significantly, reaching a market value of 44.303 billion yuan, with a maximum increase of over 11 times compared to its three-year low [7] - The company reported a revenue of 4.944 billion yuan in the first half of the year, a year-on-year increase of 38.18%, with a net profit of 432 million yuan, reflecting a growth of 20.76% [7]

Core Insights - Jiangsu Province has issued the first national drug production license utilizing 3D printing technology, marking a significant advancement in the research and industrialization of 3D printed pharmaceuticals in China [1] - The confidence of pharmaceutical companies in 3D printing technology is greatly encouraged by this development [1] Group 1: Market Performance - As of September 10, 2023, 3D printing concept stocks have seen an average increase of 37.05% this year [1] - Zhongzhou Special Materials has the highest increase at 192%, followed by Huazhu High-Tech with an increase of 111.02% [1] Group 2: Institutional Research - Seven 3D printing concept stocks have been investigated by institutions 10 times or more this year, including Dazhu Laser, Aobi Zhongguang-UW, and others [1] - Dazhu Laser leads with 72 institutional investigations, while Aobi Zhongguang-UW has been investigated 21 times [2]